Aegis Capital Corp. acted as Sole Lead Placement Agent on a $15 Million Registered Direct Offering of American Depositary Shares and Pre-Funded Warrants to Purchase American Depositary Shares for Molecular Data Inc. (NASDAQ: MKD)
Molecular Data Inc. has announced a $15 million registered direct offering of American Depositary Shares (ADS) and pre-funded warrants, with Aegis Capital Corp. acting as the sole lead placement agent. This offering aims to enhance the Company's financial position and support growth initiatives in its technology-driven platform focused on China's chemical industry. The funds will be utilized for e-commerce solutions and other strategic investments to address challenges in the chemical value chain.
- A successful $15 million direct offering aims to bolster financial stability.
- Funds are intended for growth initiatives and enhancing e-commerce solutions.
- Potential dilution of shares due to the offering.
NEW YORK, NY / ACCESSWIRE / September 20, 2021 /
About Molecular Data Inc.
Molecular Data Inc. is a leading technology-driven platform in China's chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company's e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data WeChat account, Chemical Community APP and other ancillary platforms.
About Aegis Capital Corporation
Aegis Capital Corporation ("Aegis") has been in the wealth management and investment banking business since 1984. Aegis is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis also provides research and sales and trading services to institutional investors. Aegis offers its investment representatives a conflict free service platform and is able to provide a full-range of products and services including investment banking, wealth management, insurance, retirement planning, structured products, private equity, alternatives, equity research, fixed income and special purpose vehicles.
For more information about this offering or Investment Banking Services please email Banking@aegiscap.com or call (212) 813-1010.
Brokerage and investment advisory services are offered through Aegis Capital Corporation, a member of FINRA and SIPC. Investment and insurance products offered are not insured by the FDIC or any other federal government agency, are not deposits or other obligations of, or guaranteed by, a bank or any bank affiliate, and are subject to investment risks, including possible loss of the principal amount invested.
SOURCE: Aegis Capital Corp.
View source version on accesswire.com:
https://www.accesswire.com/664792/Aegis-Capital-Corp-acted-as-Sole-Lead-Placement-Agent-on-a-15-Million-Registered-Direct-Offering-of-American-Depositary-Shares-and-Pre-Funded-Warrants-to-Purchase-American-Depositary-Shares-for-Molecular-Data-Inc-NASDAQ-MKD
FAQ
What is the size of the offering from Molecular Data Inc. (MKD)?
Who is the placement agent for the Molecular Data Inc. (MKD) offering?
What will the funds from the offering be used for regarding Molecular Data Inc. (MKD)?
How might the offering impact shareholders of Molecular Data Inc. (MKD)?
